Invesaro

Stocks ADSK Financial statements

Financial statements

Autodesk, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Autodesk, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue2,0312,0572,5703,2743,7904,3865,0055,4976,1317,206
Cost of revenue342303286325337418480511578650
Gross profit1,6891,7532,2842,9493,4533,9684,5254,9865,5536,556
Research and development7667567258519321,1151,2191,3731,4851,643
Selling and marketing1,0231,0871,1841,3101,4401,6231,7451,8232,0002,373
General and administrative288305340406414572532620650693
Operating expenses2,1892,2622,3092,6062,8243,3503,5363,8584,1994,978
Operating income-500-509-253436296189891,1281,3541,578
Interest expense83717180
Interest income21918583
Other non-operating income8.5616.85.27812467
Pre-tax income-524-557-42.72955475659461,1361,3841,603
Income tax58.39.638.180.3-66168123230272479
Net income-582-567-80.82151,2084978239061,1121,124
EBITDA-360-40170.24707537661,1391,2671,5341,773
EPS, basic-2.61-2.58-0.370.985.522.263.814.235.175.28
EPS, diluted-2.61-2.58-0.370.965.442.243.784.195.125.23
Shares, basic (weighted)223220219220219220216214215213
Shares, diluted (weighted)223220219223222222218216217215

Balance sheet

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash and equivalents1,2131,0788861,7751,7721,5281,9471,8921,5992,249
Short-term investments68724567.6694236125354287348
Receivables4524384746526437169618761,0081,439
Other current assets108117192163206284308457588906
Total current assets2,4611,8781,6202,6592,6262,7643,3413,5793,4824,942
Property, plant and equipment159145150162193162144121117121
Lease right-of-use assets0439417305245224169157
Goodwill1,5611,6202,4512,4452,7073,6043,6253,6534,2424,295
Intangible assets45.727.110670.9199494407406574467
Long-term investments3061910045102234267376
Other non-current assets2021713383473764925606027771,267
Total assets4,7984,1144,7296,1797,2808,6079,4389,91210,83312,467
Accounts payable93.594.710283.7123121102100242422
Accrued liabilities238251281272323341358476506659
Deferred revenue1,2701,5521,7632,1762,5012,8633,2033,5003,7874,406
Short-term debt0
Total current liabilities2,1852,1232,3013,2193,2554,0094,0004,3515,1515,808
Long-term debt1,0921,5862,0881,6351,6372,2782,2812,2841,9872,483
Lease liabilities0412396346300275214199
Other non-current liabilities138149122120140149139190287424
Total liabilities4,0654,3704,9406,3186,3157,7588,2938,0578,2129,422
Total debt1,0921,5862,0882,1001,6502,6502,3002,3002,3002,500
Paid-in capital1,8761,9532,0722,3172,5792,9233,3253,8024,2394,709
Retained earnings-964-2,085-2,147-2,296-1,488-1,950-1,995-1,713-1,333-1,432
Other comprehensive income-179-124-135-160-126-124-185-234-285-232
Shareholders' equity734-256-211-1399658491,1451,8552,6213,045
Total equity734-256-211-1399658491,1451,8552,6213,045
Total liabilities and equity4,7984,1144,7296,1797,2808,6079,4389,91210,83312,467
Shares outstanding220218219219220218215214214212

Cash flow statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Net income-582-567-80.82151,2084978239061,1121,124
Depreciation and amortization13910895.2127124148150139180195
Stock-based compensation222261250362398555657703683788
Change in receivables20213.3-25.4-17913-66-24786-132-431
Change in payables2.7-13.9-58.5-90.8130103627238455
Cash from operations1700.93771,4151,4371,5312,0711,3131,6072,452
Capital expenditures-76-50.7-67-53.2-91-56-40-31-40-43
Acquisitions-85.20-1,0400-246-1,250-96-70-8250
Purchases of investments-13.8-12.2-138-19.9-21-311-397-1,110-815-945
Sales and maturities of investments1,05759421151726298487638467
Cash from investing272506-710-57.3-404-1,595-143-502-903-451
Debt issued04975004990997000499
Stock issued12094.490.993.7114114124130121137
Share buybacks-622-699-294-443-552-1,079-1,101-795-852-1,402
Dividends paid00000000
Cash from financing-578-657152-467-1,047-169-1,487-852-987-1,361
Exchange rate effect-3.314.2-10.6-2.311-11-22-14-1010
Net change in cash-140-135-192889-3-244419-55-293650
Free cash flow93.7-49.83101,3621,3461,4752,0311,2821,5672,409
Interest paid47.654.65967.8635886696976
Income taxes paid77.784.57860.393165241321281258

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to July 31, 2026; growth uses fiscal years. Valuation uses the share price of $209.40 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin91.2%Gross profit / revenue.
Operating margin26.2%Operating income / revenue.
EBITDA margin28.8%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin27.0%Pre-tax income / revenue.
Net margin21.1%Net income / revenue.
FCF margin36.4%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin37.2%Cash from operations / revenue.
Effective tax rate22.0%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)48.5%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)12.6%Net income / average total assets.
Return on invested capital (ROIC)89.2%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue22.1%Research and development expense / revenue.
Stock-based pay / revenue9.1%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue0.7%Capital expenditures / revenue.
D&A / revenue2.6%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y17.5%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y12.9%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y13.7%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y18.1%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y13.2%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y13.7%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y16.5%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y16.9%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y20.2%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y15.6%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y15.9%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y18.7%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y1.1%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y10.9%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y-1.4%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y2.1%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y11.4%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y-0.8%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y52.6%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y5.8%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y11.3%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y53.7%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y5.9%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y12.3%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y16.2%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y38.5%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y25.8%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y15.1%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y9.7%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y11.4%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-0.9%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-0.5%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-0.6%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio0.86xCurrent assets / current liabilities.
Quick ratio0.73x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.63x(Cash + short-term investments) / current liabilities.
Debt / equity0.74xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets19.3%Total debt / total assets.
Liabilities / assets73.9%Total liabilities / total assets.
Net debt-$1.66BTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA-0.74xNet debt / EBITDA (twelve months), when EBITDA is positive.
Working capital-$958.0MCurrent assets - current liabilities.
Goodwill and intangibles / assets36.6%(Goodwill + intangible assets) / total assets.
Tangible book value-$1.37BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.60xRevenue / average total assets.
Fixed asset turnover62.8xRevenue / average property, plant and equipment.
Receivables turnover11.4xRevenue / average receivables.
Days sales outstanding32 days365 x average receivables / revenue.
Days payables245 days365 x average accounts payable / cost of revenue.
FCF conversion172.9%Free cash flow / net income, when net income is positive.
Capex / operating cash flow2.0%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$7.78Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$36.92Revenue / diluted weighted shares.
FCF per share$13.46Free cash flow / diluted weighted shares.
Operating cash flow per share$13.73Cash from operations / diluted weighted shares.
Book value per share$16.03Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share-$6.50Tangible book value / shares outstanding.
Cash per share$19.69(Cash + short-term investments) / shares outstanding.
Buybacks / FCF56.0%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$44.18BShare price x shares outstanding.
Enterprise value$42.53BMarket cap + total debt - cash - short-term investments.
P/E26.9xMarket cap / net income. Only when net income is positive.
P/S5.67xMarket cap / revenue.
P/B13.1xMarket cap / shareholders' equity. Only when equity is positive.
P/FCF15.6xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF15.3xMarket cap / cash from operations, when positive.
EV/Sales5.46xEnterprise value / revenue.
EV/EBIT20.8xEnterprise value / operating income, when both are positive.
EV/EBITDA19.0xEnterprise value / EBITDA, when both are positive.
EV/FCF15.0xEnterprise value / free cash flow, when both are positive.
FCF yield6.4%Free cash flow / market cap.
Earnings yield3.7%Net income / market cap (the inverse of P/E).
Shareholder yield3.6%(Dividends paid + share buybacks) / market cap.
PEG2.35xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was Autodesk, Inc.'s revenue in fiscal 2026?

Autodesk, Inc. reported revenue of $7.21B for fiscal 2026, 17.5% higher than the year before.

Was Autodesk, Inc. profitable in fiscal 2026?

Yes. Net income was $1.12B, a net margin of 15.6%.

How much free cash flow did Autodesk, Inc. generate in fiscal 2026?

Cash from operations of $2.45B minus capital expenditures of $43.0M left free cash flow of $2.41B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Autodesk, Inc.